Seeburg K N, DeBoer K F
Biofeedback Self Regul. 1980 Jun;5(2):289-93. doi: 10.1007/BF00998605.
A case is described in which a juvenile-onset insulin-requiring diabetic was given frontalis EMG biofeedback. For 6 years prior to biofeedback training, the subject had been healthy and stable on 22-24 units regular insulin injected once daily. During 8 weeks of standard feedback training for relaxation of frontalis muscle activity, the subject twice reduced her daily insulin dosages. At the end of 8 weeks, the subject was receiving 17-18 units regular insulin daily but was still unstable, sometimes being hyperglycemic, sometimes hypoglycemic. Because of disturbing symptoms associated with this instability, biofeedback was discontinued for 6 months, at which time the subject was again healthy and stable on the equivalent of 18-19 units regular insulin daily. After this period, biofeedback was again given for 1 week, but the subject again became highly unstable and biofeedback was permanently stopped. Caution is suggested when dealing with diabetic patients.
本文描述了一个病例，一名青少年起病的胰岛素依赖型糖尿病患者接受了额肌肌电图生物反馈治疗。在进行生物反馈训练前的6年里，该患者健康状况良好，每天注射22 - 24单位常规胰岛素，病情稳定。在为期8周的额肌肌肉活动放松标准反馈训练期间，该患者两次减少了每日胰岛素剂量。8周结束时，该患者每天接受17 - 18单位常规胰岛素，但病情仍不稳定，有时血糖过高，有时血糖过低。由于这种不稳定相关的不适症状，生物反馈治疗中断了6个月，在此期间，该患者再次恢复健康，每天使用相当于18 - 19单位常规胰岛素，病情稳定。在此之后，再次进行了1周的生物反馈治疗，但该患者再次变得高度不稳定，生物反馈治疗被永久停止。在治疗糖尿病患者时建议谨慎行事。
